Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized single-blind trial. This study aimed to determine if intensive
lipid-lowering therapy (simvastatin-ezetimibe combination therapy) could reduce the
progression of atherosclerosis effectively and safely among SLE patients with carotid artery
intima thickening. The study results were expected to be helpful for SLE patients in
preventing atherosclerosis.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin